USFDA recommends that Cipla hire a consultant to meet cGMP requirements

The recommendation is part of the USFDA’s warning letter to Cipla, following cGMP violations at its Pithampur plant in Indore

Leave a comment

Your email address will not be published. Required fields are marked *